When compared with Oh et al.’s study [8], the benefit of accumulative and relatively stably maintained expression of RBM5 in tumors in our in vivo study could better reflect the potential therapeutic role of RBM5 in effective inhibition of lung cancer cell growth. This evidence concerns the gene RBM5 and lung carcinoma.